Jpmorgan Chase & CO Teva Pharmaceutical Industries LTD Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Jpmorgan Chase & CO holds 2,021,961 shares of TEVA stock, worth $45.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,021,961
Previous 5,032,516 59.82%
Holding current value
$45.1 Million
Previous $81.8 Million 55.45%
% of portfolio
0.0%
Previous 0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 26, 2024
SELL
$15.81 - $18.96 $47.6 Million - $57.1 Million
-3,010,555 Reduced 59.82%
2,021,961 $36.4 Million
Q3 2024

Nov 08, 2024
SELL
$15.81 - $18.96 $47.6 Million - $57.1 Million
-3,010,555 Reduced 59.82%
2,021,961 $36.4 Million
Q2 2024

Dec 26, 2024
BUY
$12.78 - $17.4 $38.5 Million - $52.4 Million
3,010,555 Added 148.89%
5,032,516 $81.8 Million
Q2 2024

Aug 12, 2024
BUY
$12.78 - $17.4 $25.9 Million - $35.2 Million
2,024,898 Added 67.33%
5,032,516 $81.8 Million
Q1 2024

Dec 26, 2024
BUY
$10.67 - $14.43 $10.5 Million - $14.2 Million
985,657 Added 48.75%
3,007,618 $42.4 Million
Q1 2024

May 10, 2024
BUY
$10.67 - $14.43 $9.55 Million - $12.9 Million
895,238 Added 42.38%
3,007,618 $42.4 Million
Q4 2023

Dec 26, 2024
BUY
$8.12 - $10.63 $734,202 - $961,153
90,419 Added 4.47%
2,112,380 $22.1 Million
Q4 2023

Feb 12, 2024
BUY
$8.12 - $10.63 $9.36 Million - $12.3 Million
1,152,610 Added 120.09%
2,112,380 $22.1 Million
Q3 2023

Nov 14, 2023
SELL
$7.48 - $10.7 $1.14 Million - $1.63 Million
-152,617 Reduced 13.72%
959,770 $9.79 Million
Q2 2023

Aug 11, 2023
SELL
$7.2 - $9.47 $1.15 Million - $1.51 Million
-159,513 Reduced 12.54%
1,112,387 $8.38 Million
Q1 2023

May 11, 2023
BUY
$8.36 - $11.37 $5.52 Million - $7.51 Million
660,539 Added 108.04%
1,271,900 $11.3 Million
Q4 2022

Feb 13, 2023
BUY
$7.95 - $9.48 $53,352 - $63,620
6,711 Added 1.11%
611,361 $5.58 Million
Q3 2022

Nov 14, 2022
BUY
$6.86 - $11.95 $457,349 - $796,694
66,669 Added 12.39%
604,650 $4.88 Million
Q2 2022

Aug 11, 2022
SELL
$7.38 - $10.4 $53,947 - $76,024
-7,310 Reduced 1.34%
537,981 $4.05 Million
Q1 2022

May 11, 2022
SELL
$7.33 - $9.39 $502,141 - $643,261
-68,505 Reduced 11.16%
545,291 $5.12 Million
Q4 2021

Feb 10, 2022
BUY
$7.9 - $10.19 $184,733 - $238,282
23,384 Added 3.96%
613,796 $4.92 Million
Q3 2021

Nov 12, 2021
BUY
$8.38 - $10.18 $4.95 Million - $6.01 Million
590,412 New
590,412 $5.75 Million

Others Institutions Holding TEVA

# of Institutions
625
Shares Held
573M
Call Options Held
19.6M
Put Options Held
6.77M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $24.8B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email